In Full Health In Full Health

 
  • HOME
  • BUSINESS CASE
  • OUR PRINCIPLES
  • LEARN & TAKE ACTION ▼
    • RESOURCES TO LEARN & TAKE ACTION
      • In Full Health Equitable Health Innovation Solution Development Toolkit
    • JOIN THE COMMUNITY
  • IN FULL HEALTH BLOG
  • ABOUT US
  • CONTACT US
In Full Health In Full Health
  • HOME
  • BUSINESS CASE
  • OUR PRINCIPLES
  • LEARN & TAKE ACTION ▼
    • RESOURCES TO LEARN & TAKE ACTION
      • In Full Health Equitable Health Innovation Solution Development Toolkit
    • JOIN THE COMMUNITY
  • IN FULL HEALTH BLOG
  • ABOUT US
  • CONTACT US
In Full Health / Resources / Articles / The Emerging Role of Pharma in Value-Based Care
Jan 24
The Emerging Role of Pharma in Value-Based Care
  • Articles, Resources
  • Data, equitable health innovation, health disparities, health innovation, pharma, value-based care

While care providers and health plans have historically viewed the pharma industry as somewhat separate from value-based care, the push to achieve healthcare’s quintuple aim across the care continuum is shining a light on shared goals—and highlighting the need for partnerships that transcend any perceived divides.

Medication adherence is a prime example. About half of all chronic disease patients fail to take their medications as prescribed, contributing to more than 125,000 preventable deaths and over $500 billion in avoidable medical spending each year. Clearly, addressing this dire situation is good for patients and their outcomes. But in the value-based care environment, the benefits of medication adherence extend even further.

For pharma, the growing focus on medication for chronic disease management in value-based care represents an opportunity to broaden access to ground-breaking therapies. However, it involves a major shift in thinking about how to sell and market new or existing medications. Rather than relying on traditional approaches, such as direct-to-consumer advertisements, commercial teams instead need to develop innovative new strategies to educate consumers and prescribers on the importance of adherence. Collaborating with health plans and technology providers is a practical approach.

Read the full article below.


Related Posts

  • Data-Driven DEI: The Tools and Metrics You Need to Measure, Analyze, and Improve Diversity, Equity, and Inclusion, 2023February 15, 2024
  • AMA Issues New Principles for AI Development, Deployment & UseJanuary 23, 2024
  • NHIT @ AWS Summit DC 2022 – Driving insights using modern data architecturesJuly 11, 2022
  • Increasing Diversity in Clinical Research and Addressing Health Inequities. DeChane Dorsey. AdvaMed Accel, 25 May 2022.June 13, 2022

Comments are closed.

Categories

  • Health Equity
  • Health Equity Innovation
  • WP Categories

    • Blog 49
      • Health Equity 25
      • Health Equity Innovation 38
    • Podcast 11
    • Resources 124
      • Articles 39
      • Books 9
      • Educational Modules 2
      • Events 2
      • Films 5
      • Initiatives 19
      • Podcast 5
      • Reports 24
      • Tools 20
      • Videos 3

Terms of Use | Privacy Policy| Code of Conduct | Website Accessibility

© Copyright 2025 American Medical Association